SH Kelkar Sells Italian Unit, Stock Dips as Investors Scrutinize Deal

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorAarav Shah|Published at:
SH Kelkar Sells Italian Unit, Stock Dips as Investors Scrutinize Deal
Overview

SH Kelkar and Company Ltd. has approved the sale of its 17% equity stake in CFF Keva Italy S.p.A. to Keva Italy Srl for up to €12.5 million, with completion expected by September 30, 2026. This move aims to consolidate Keva Group's European subsidiaries under Keva Europe BV. The divested Italian subsidiary contributed ₹358.04 crore in revenue for fiscal year 2025, representing 16.86% of SH Kelkar's consolidated revenue. The announcement on March 13, 2026, coincided with a 6.23% drop in SH Kelkar's share price, closing at ₹121.20 on the BSE.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Key Sale Details Emerge

SH Kelkar and Company Ltd. is selling its 17% stake in CFF Keva Italy S.p.A. to its fully owned subsidiary, Keva Italy Srl. The deal is valued at up to €12.5 million (around ₹112.5 crore) and is set to finish by September 30, 2026. The sale led to an immediate negative market reaction, with SH Kelkar shares falling 6.23% on March 13, 2026, to ₹121.20 on the BSE. This drop suggests investors are questioning the divestment of a unit that generates significant revenue, despite the company's goal to simplify its European operations under Keva Europe BV.

Italian Unit's Financial Impact

CFF Keva Italy S.p.A. played a significant role in SH Kelkar's finances. In fiscal year 2025, it brought in ₹358.04 crore in revenue, making up 16.86% of SH Kelkar's total consolidated revenue. Its total income was ₹359.40 crore (16.74% of consolidated total income), and its net worth stood at ₹94.35 crore (7.42% of consolidated net worth). The sale price of up to €12.5 million is roughly 1.3 times the subsidiary's net worth at the end of FY25. While this multiple isn't extremely low, investors are examining it closely given the unit's revenue contribution. This transaction is considered a related-party deal under SEBI rules but is being handled at arm's length. Keva Italy Srl, the buyer, was established in 2019 as part of Keva's global expansion and is not part of the promoter group. The sale is not a slump sale or part of a scheme of arrangement.

Valuation Mixed Amid Sector Growth

As of March 12, 2026, SH Kelkar's market value was about ₹17.88 billion. Its Price-to-Earnings (P/E) ratio has varied, reported around 13.59 (TTM for February 2026) and 27.92 (TTM). Other reports show a P/E as low as 10.7 on March 10, 2026. This valuation appears mixed, especially when compared to recent analyst target prices of ₹370.00, which suggest significant potential gains not currently reflected in the market's mood. SH Kelkar operates in India's specialty chemicals sector, which is expected to grow substantially, potentially reaching over $60 billion by 2026, driven by economic development. However, the sector also faces hurdles like environmental regulations and international competition. Companies like Pidilite Industries, SRF, and Solar Industries India are active in similar areas. Despite reporting 17% year-over-year sales growth for the first nine months of FY25, SH Kelkar's stock has performed poorly, down 27.73% over the past year. MarketsMojo rated the stock a 'Strong Sell' as of March 9, 2026, citing average quality, negative financial trends, and bearish technical indicators.

Concerns Over Divestment Rationale

Investors may be reacting negatively because they suspect SH Kelkar is selling a major revenue source to fix underlying issues or debt problems, rather than just simplifying its structure. While the Keva Group aims for a clearer European ownership setup, divesting a unit responsible for nearly 17% of consolidated revenue raises questions about the company's ability to grow organically or the profitability of its European operations. Even though the related-party sale is at arm's length, investors sometimes view such deals with caution regarding fairness and openness. SH Kelkar's past financial results show fluctuating operating profits and a dip in profit after tax for FY25, even with higher sales. Investors have also noted concerns about interest capitalization and a reduction in promoter holdings over the past three years. The company's management has also pledged more shares, which could indicate liquidity challenges. With previous European acquisitions, like PFW Aroma Ingredients in January 2023, this divestment might signal a shift in its international strategy, possibly due to underperformance or a need to improve its financial standing.

Looking Ahead

Despite the recent stock sell-off, SH Kelkar has projected ambitious sales targets, aiming for ₹3,377 crore by FY29 and a total income growth rate (CAGR) of about 10% over five years. The company continues to invest in expanding its global reach and production capacity. However, analyst views remain divided, with some predicting strong price increases and others issuing 'Strong Sell' ratings. The finalization of the sale agreement by September 30, 2026, and how CFF Keva Italy is integrated into Keva Italy Srl will be closely watched. SH Kelkar's success in turning its investments into better profits and lasting value, especially with ongoing market competition and cost pressures, will determine its future performance.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.